News

Sudden cardiac death (SCD) is the leading cause of death in high school-aged athletes. To determine if SCD can be prevented with a heart screening, The Christ Hospital Health Network (Cincinnati, Ohio), The University of Mississippi Medical...

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval of its next-generation Ellipse™ and SJM Assura™ portfolio of implantable cardioverter defibrillators (ICDs)...

Valley Heart & Vascular Institute (HVI) electrophysiologist Aysha Arshad, M.D., and her cardiac research were recognized by the international Heart Rhythm Society with the organization’s prestigious 2013 Highest Scoring Abstract Award to...

Taking a more in-depth look at the data behind the March 2013 FDA announcement, CardioReady aims to support FDA commentary on AED safety and effectiveness CardioReady, a national leader in helping to prevent fatalities from Sudden Cardiac...

Diagnostic-Quality Image Access and Collaboration for all Central New York Providers eHealth Technologies, a leader in streamlining transitions of care including, securely delivering electronic diagnostic images to the users of health...

eHealth Technologies continues to lead the way in image-enabling technologies with the eHealthViewer® ZF, a zero footprint viewer that enables clinicians, with any secure browser to instantly access their patients’ medical images, in...

St. Jude Medical, Inc., a global medical device company, announced U.S. Food and Drug Administration (FDA) approval to begin the EnligHTN IV Renal Denervation Study, the first U.S. trial using the EnligHTN™ Multi-Electrode Renal Denervation...

TYRX, Inc., the leader in the commercialization of implantable medical devices designed to help reduce surgical-site infections associated with implantable devices including pacemakers and defibrillators, announced today it has received a...

Article in EP Lab Digest discusses comprehensive posterior left atrial wall ablation and highlights maintenance of sinus rhythm at 13 months’ follow-up EP Lab Digest has published the second part of a series of single-center outcomes using...

Article in Arrhythmia and Electrophysiology Review discusses Allegheny General Hospital’s experience in maintaining sinus rhythm at 12 months’ follow-up with no major adverse events Morrisville, NC – May 30, 2013 -...